This company listing is no longer active
Xebec Adsorption Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Wichtige Informationen
n/a
Wachstumsrate der Gewinne
n/a
EPS-Wachstumsrate
Machinery Gewinnwachstum | 11.6% |
Wachstumsrate der Einnahmen | n/a |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2023 | 351 | N/A | -23 | N/A | 1 |
6/30/2022 | 155 | -66 | -37 | -26 | N/A |
3/31/2022 | 144 | -32 | -59 | -48 | N/A |
12/31/2021 | 123 | -23 | -68 | -57 | N/A |
9/30/2021 | 84 | -37 | -52 | -43 | N/A |
6/30/2021 | 77 | -30 | -41 | -37 | N/A |
3/31/2021 | 64 | -41 | -49 | -46 | N/A |
12/31/2020 | 57 | -32 | -28 | -27 | N/A |
9/30/2020 | 64 | -4 | -22 | -20 | N/A |
6/30/2020 | 59 | -1 | -19 | -16 | N/A |
3/31/2020 | 52 | 1 | -7 | -4 | N/A |
12/31/2019 | 49 | 2 | -8 | -5 | N/A |
9/30/2019 | 42 | 1 | -7 | -6 | N/A |
6/30/2019 | 34 | 0 | -5 | -5 | N/A |
3/31/2019 | 27 | -1 | -6 | -5 | N/A |
12/31/2018 | 20 | -3 | -3 | -3 | N/A |
9/30/2018 | 17 | -3 | -1 | 0 | N/A |
6/30/2018 | 16 | -2 | -1 | 0 | N/A |
3/31/2018 | 15 | -2 | -1 | -1 | N/A |
12/31/2017 | 15 | 0 | -2 | -2 | N/A |
9/30/2017 | 15 | 1 | -3 | -3 | N/A |
6/30/2017 | 12 | 0 | -4 | -4 | N/A |
3/31/2017 | 10 | -1 | -3 | -3 | N/A |
12/31/2016 | 10 | -3 | -3 | -3 | N/A |
9/30/2016 | 10 | -4 | -3 | -3 | N/A |
6/30/2016 | 11 | -4 | -2 | -2 | N/A |
3/31/2016 | 11 | -4 | N/A | -2 | N/A |
12/31/2015 | 11 | -3 | N/A | -1 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: Insufficient data to determine if XB6's forecast earnings growth is above the savings rate (0.03%).
Ertrag vs. Markt: Insufficient data to determine if XB6's earnings are forecast to grow faster than the German market
Hohe Wachstumserträge: Insufficient data to determine if XB6's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: Insufficient data to determine if XB6's revenue is forecast to grow faster than the German market.
Hohe Wachstumseinnahmen: Insufficient data to determine if XB6's revenue is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if XB6's Return on Equity is forecast to be high in 3 years time